| |
|
|
|
Xtalks, online
2023 -9-28
Pediatric rare disease trials combine rarity of disease with a restricted and geographically-dispersed population of vulnerable subjects for research, creating unique challenges for study design and execution. Recruitment is challenging, as patients, parents and caregivers need to juggle school schedules, work responsibilities and family obligations to accommodate study participation.
Incorporating decentralized clinical trial (DCT) strategies can help sponsors attract patients and increase access, enrollment and retention by limiting site visits and facilitating participation for those who might not otherwise be able — or willing — to travel to distant sites or specialized centers.
Join this webinar to learn:
Challenges of conducting clinical research in pediatric rare diseases
Potential applications of DCT strategies in pediatric rare disease studies
Risks to applying DCT strategies in these clinical trials
Key considerations when operationalizing pediatric rare disease studies with decentralized elements
Future trends in decentralization for pediatric rare disease studies
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Betsy Reid, Senior Vice President, Pediatrics, Premier Research Dr. Adam Bloomfield, MD, FAAP, Executive Director, Medical Affairs, Rare Diseases and Pediatrics, Premier Research
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -9-28
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|